Logo

GenMark

Roche Diagnostics Q1 Sales Climb 50 Percent

The firm's diagnostics growth was driven by COVID-19 test sales with point-of-care sales skyrocketing year over year.

GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock

The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month.

Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing
Premium

Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally.

Roche to Acquire GenMark Diagnostics for $1.8B

Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share.

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.

Feb 26, 2021

GenMark Diagnostics Seeing Continued Demand for Respiratory Panels, Plans 510(k) Submission
Premium

Feb 25, 2021

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

Feb 11, 2021

GenMark Shares Rise on Acquisition Rumors

Jan 13, 2021

JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More

Jan 11, 2021

GenMark Diagnostics Preliminary Q4 Revenues Rise 84 Percent on ePlex Molecular Diagnostics Sales

Oct 29, 2020

GenMark Diagnostics Expanding Manufacturing to Meet Pent Up Demand for SARS-CoV-2, Respiratory Panel
Premium

Oct 28, 2020

GenMark Q3 Revenues More Than Double on Respiratory Panel Sales

Oct 8, 2020

GenMark Sees Jump in Preliminary Q3 Revenues, Nabs Respiratory Panel FDA Emergency Use Authorization

Sep 14, 2020

GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu

Sep 8, 2020

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza
Premium

Sep 1, 2020

Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent

Aug 27, 2020

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

Aug 4, 2020

GenMark Diagnostics Q2 Revenues More Than Double on COVID-19 Testing

Jul 7, 2020

GenMark Diagnostics Preliminary Q2 Revenues Rise 118 Percent on SARS-CoV-2 Tests

Jul 2, 2020

Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

Jul 1, 2020

Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index

Jun 1, 2020

Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details

May 7, 2020

GenMark Diagnostics, Chembio Diagnostics Price Stock Offerings

May 4, 2020

GenMark Diagnostics Q1 Revenues Grow 80 Percent

May 1, 2020

GenomeWeb Index Recovers in April as Life Science Industry Focuses on Coronavirus Test Development

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.